Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,975,156
in 10 filings, $2.0M under 10b5-1 plans

Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-13 Mutz Christopher HEAD OF RARE DISEASE Sale 10b5-1 −3,162 $71.64 $227K 91,309
2026-03-09 Mutz Christopher HEAD OF RARE DISEASE Sale 10b5-1 −3,602 $74.18 $267K 94,471
2026-03-07 Mutz Christopher HEAD OF RARE DISEASE Shares withheld for taxes 10b5-1 −3,314 $74.04 $245K 98,073
2026-03-06 Mutz Christopher HEAD OF RARE DISEASE Sale 10b5-1 −2,121 $74.22 $157K 101,387
2026-03-02 Mutz Christopher HEAD OF RARE DISEASE Sale 10b5-1 −417 $74.00 $31K 103,508
2026-02-28 Mutz Christopher HEAD OF RARE DISEASE Shares withheld for taxes −2,221 $73.90 $164K 103,925
2026-02-26 Mutz Christopher HEAD OF RARE DISEASE Grant or award +21,306 $77.15 $1.6M 106,146
2026-02-20 Mutz Christopher HEAD OF RARE DISEASE Sale 10b5-1 −5,323 $78.02 $415K 84,840
2026-02-14 Mutz Christopher HEAD OF RARE DISEASE Shares withheld for taxes 10b5-1 −2,403 $77.36 $186K 90,163
2026-02-12 Mutz Christopher HEAD OF RARE DISEASE Shares withheld for taxes 10b5-1 −3,173 $76.70 $243K 99,598
2026-02-12 Mutz Christopher HEAD OF RARE DISEASE Sale 10b5-1 −7,032 $76.55 $538K 92,566
2026-02-11 Mutz Christopher HEAD OF RARE DISEASE Shares withheld for taxes −4,546 $76.25 $347K 102,771
2025-05-14 Mutz Christopher HEAD OF RARE DISEASE Sale −4,000 $60.45 $242K 107,317
2025-03-07 Mutz Christopher HEAD OF RARE DISEASE Shares withheld for taxes −2,874 $60.62 $174K 111,317
2025-02-28 Mutz Christopher HEAD OF RARE DISEASE Shares withheld for taxes −1,275 $61.89 $79K 114,191
2025-02-15 Mutz Christopher HEAD OF RARE DISEASE Shares withheld for taxes −1,184 $58.92 $70K 115,466
2025-02-14 Mutz Christopher HEAD OF RARE DISEASE Shares withheld for taxes −1,473 $58.92 $87K 116,650
2025-02-12 Mutz Christopher HEAD OF RARE DISEASE Grant or award +24,808 101,585
2025-02-12 Mutz Christopher HEAD OF RARE DISEASE Grant or award +16,538 118,123
2024-11-15 Mutz Christopher HEAD OF RARE DISEASE Sale −6,500 $57.70 $375K 76,777

Page 1 of 2 · 38 trades